Brief: Biosergen Completes First Cohort Of Bsg005 Phase I Trial

Biosergen AB

13/05/2022 14:34

May 13 (Reuters) - Biosergen AB  BIOSGN.ST :
    * SUCCESSFULLY COMPLETES FIRST COHORT OF BSG005 PHASE I
TRIAL
    * SAFETY REVIEW COMMITTEE FOUND NO SAFETY ISSUES IN FIRST
6-VOLUNTEER COHORT IN SINGLE ASCENDING DOSE PART OF BSG005'S
PHASE I TRIAL

Source text for Eikon:  ID:nWkr70p52q 
Further company coverage:  BIOSGN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))